Get my own profile
Public access
View all25 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Steven de JongProfessor of Preclinical and Translational Oncology, University Medical Center GroningenVerified email at umcg.nl
GJ PetersProfessor of Pharmacology of Cytostatics, Amsterdam UMC, location VUMC, Amsterdam; and MedicalVerified email at amsterdamumc.nl
Elisabeth de VriesProfessor of Medical Oncology, University Medical Center Groningen, Groningen, the NetherlandsVerified email at umcg.nl
Anke van den BergProfessor of Molecular biology of malignant B cell lymphomas, University of Groningen, UniversityVerified email at umcg.nl
Mohamed Abou El HassanClinical Biochemist, LifeLabs; Assistant Professor, Department of Pathology, DalhousieVerified email at lifelabs.com
Milind PoreScientist IIVerified email at nih.gov
Wim J. QuaxProfessor of Pharmaceutical BiologyVerified email at rug.nl
Gerard PalsAmsterdam University medical centers Amsterdam, The Netherlands; Universitas Gadjah Mada, YogyakartaVerified email at amsterdamumc.nl
Maureen HoatlinOregon Health & Science UniversityVerified email at ohsu.edu
Kirill Basiliyainterventional endoscopist, Leiden University Medical Center
Tushar TomarDirector , Durg Development Operations; OncoLize B.V.; The Netherlands